Log in
Enquire now
OpenEvidence

OpenEvidence

Launched during the Mayo Clinic Platform Accelerate program and featured by the New England Journal of Medicine AI, OpenEvidence is the world’s leading medical AI.

OverviewStructured DataIssuesContributors

Contents

openevidence.com
Is a
Company
Company

Company attributes

Industry
Artificial Intelligence (AI)
Artificial Intelligence (AI)
‌
Data Analytics
Health technology
Health technology
Location
Cambridge, Massachusetts
Cambridge, Massachusetts
B2X
B2B
B2B
Founder
‌
Daniel Nadler
Number of Employees (Ranges)
11 – 50
Email Address
contact@openevidence.com
Investors
Conviction Capital
Conviction Capital
Sequoia Capital
Sequoia Capital
Coatue Management
Coatue Management
Thrive Capital
Thrive Capital
Google Ventures
Google Ventures
Kleiner Perkins Caufield & Byers
Kleiner Perkins Caufield & Byers
Total Funding Amount (USD)
1,210,000,000
Latest Funding Round Date
July 15, 2025
CTO
‌
Zachary Ziegler
Latest Funding Type
Series B
Series B

Other attributes

Latest Funding Round Amount (USD)
210,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like OpenEvidence

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.